The effect of trastuzumab emtansine (T-DM1) to the platelets for HER2-positive advanced breast cancer patients
Not Applicable
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000014750
- Lead Sponsor
- Hematology and Oncology, Mie University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. drug allergy to T-DM1 or trastuzumab 2. uncontrollable infection and diabetes mellitus 3. bleeding tendency 4. not suitable for participation with any other reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method